Viewing Study NCT02104804


Ignite Creation Date: 2025-12-24 @ 7:50 PM
Ignite Modification Date: 2026-03-19 @ 2:52 AM
Study NCT ID: NCT02104804
Status: COMPLETED
Last Update Posted: 2017-10-02
First Post: 2014-04-02
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 Diabetes Mellitus, Insulin, Dipeptidyl-Peptidase 4 Inhibitors, Metformin,saxagliptin,Endocrine System … View